(Q45052263)

8 December 2017

Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme (English)

1 reference

8 December 2017

0 references

1 reference

Broliden K

1

1 reference

8 December 2017

Abreu ER

series ordinal

2

1 reference

8 December 2017

Arneborn M

series ordinal

3

1 reference

8 December 2017

Böttiger M

series ordinal

4

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

8 December 2017

5

1 reference

inferred from page(s)

published in

Vaccine

1 reference

8 December 2017

16

1 reference

8 December 2017

2-3

1 reference

8 December 2017

323-327

1 reference

Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Scandinavian model for eliminating measles, mumps, and rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Vaccination against measles, mumps and rubella (MMR): a comparison between the antibody responses at the ages of 18 months and 12 years and between different methods of antibody titration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Symptomatic mumps virus reinfections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Mass vaccination programme aimed at eradicating measles, mumps and rubella in Sweden: vaccination of schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

Mumps vaccination and meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2988332-6

7 January 2021

10.1016/S0264-410X(97)88332-6

Identifiers

DOI

1 reference

8 December 2017

1 reference